Key O O O O
Things O O O O
to O O O O
Know O O O O
About O O O O
COVID-19 O O O O
Vaccines O O O O
12 O O O O
minute(s) O O O O
read O O O O
Share O O O O
|Please O O O O
be O O O O
informed O O O O
that O O O O
currently O O O O
Bangkok O O O O
Hospital O O O O
cannot O O O O
provide O O O O
COVID-19 O O O O
vaccination O O O O
service. O O O O
As O O O O
soon O O O O
as O O O O
the O O O O
vaccine O O O O
is O O O O
readily O O O O
available, O O O O
we O O O O
will O O O O
keep O O O O
you O O O O
updated.| O O O O
A O O O O
number O O O O
of O O O O
medical O O O O
studies O O O O
have O O O O
proved O O O O
that O O O O
COVID-19 O O O O
vaccines O O O O
are O O O O
effective O O O O
at O O O O
preventing O O O O
people O O O O
from O O O O
getting O O O O
COVID-19. O O O O
The O O O O
vaccines O O O O
do O O O O
not O O O O
only O O O O
reduce O O O O
the O O O O
chance O O O O
of O O O O
infection, O O O O
but O O O O
they O O O O
also O O O O
help O O O O
to O O O O
mitigate O O O O
disease O O O O
severity O O O O
in O O O O
case O O O O
a O O O O
person O O O O
becomes O O O O
infected. O O O O
Although O O O O
vaccines O O O O
appear O O O O
to O O O O
be O O O O
acknowledged O O O O
worldwide O O O O
due O O O O
to O O O O
their O O O O
efficacy, O O O O
people O O O O
who O O O O
have O O O O
been O O O O
fully O O O O
vaccinated O O O O
against O O O O
COVID-19 O O O O
should O O O O
still O O O O
keep O O O O
taking O O O O
precautions O O O O
and O O O O
preventive O O O O
measures O O O O
in O O O O
public O O O O
areas, O O O O
e.g. O O O O
wearing O O O O
a O O O O
mask, O O O O
maintaining O O O O
social O O O O
distancing, O O O O
avoiding O O O O
crowds O O O O
and O O O O
poorly O O O O
ventilated O O O O
spaces O O O O
as O O O O
well O O O O
as O O O O
frequent O O O O
hand O O O O
washing. O O O O
To O O O O
remain O O O O
safe O O O O
and O O O O
healthy, O O O O
it O O O O
is O O O O
essential O O O O
to O O O O
know O O O O
and O O O O
have O O O O
a O O O O
better O O O O
understanding O O O O
about O O O O
important O O O O
information O O O O
related O O O O
to O O O O
COVID-19 O O O O
vaccines O O O O
prior O O O O
to O O O O
vaccination. O O O O
Coronavirus Reason 5 O O
disease Reason 5 O O
(COVID-19) Reason 5 O O
COVID-19 Reason 5 O O
is Reason 5 O O
an Reason 5 O O
infectious Reason 5 O O
disease Reason 5 O O
caused Reason 5 O O
by Reason 5 O O
a Reason 5 O O
newly Reason 5 O O
discovered Reason 5 O O
coronavirus, Reason 5 O O
SARS-CoV-2 Reason 5 O O
which Reason 5 O O
is Reason 5 O O
a Reason 5 O O
single-stranded Reason 5 O O
RNA Reason 5 O O
virus. Reason 5 O O
Considered Reason 5 O O
as Reason 5 O O
global Reason 5 O O
pandemic, Reason 5 O O
COVID-19 Reason 5 O O
is Reason 5 O O
highly Reason 5 O O
transmissible. Reason 5 O O
The Reason 5 O O
virus Reason 5 O O
is Reason 5 O O
thought Reason 5 O O
to Reason 5 O O
primarily Reason 5 O O
spread Reason 5 O O
person-to-person Reason 5 O O
through Reason 5 O O
respiratory Reason 5 O O
droplets Reason 5 O O
produced Reason 5 O O
when Reason 5 O O
an Reason 5 O O
infected Reason 5 O O
patient Reason 5 O O
coughs Reason 5 O O
or Reason 5 O O
sneezes. Reason 5 O O
COVID-19 Reason 5 O O
can Reason 5 O O
be Reason 5 O O
transmitted Reason 5 O O
via Reason 5 O O
direct Reason 5 O O
contact Reason 5 O O
of Reason 5 O O
saliva, Reason 5 O O
nasal Reason 5 O O
discharge Reason 5 O O
and Reason 5 O O
sputum. Reason 5 O O
It Reason 5 O O
could Reason 5 O O
also Reason 5 O O
spread Reason 5 O O
if Reason 5 O O
people Reason 5 O O
touch Reason 5 O O
an Reason 5 O O
object Reason 5 O O
or Reason 5 O O
surface Reason 5 O O
with Reason 5 O O
virus Reason 5 O O
present Reason 5 O O
from Reason 5 O O
an Reason 5 O O
infected Reason 5 O O
person Reason 5 O O
and Reason 5 O O
then Reason 5 O O
touch Reason 5 O O
their Reason 5 O O
mouth, Reason 5 O O
nose Reason 5 O O
or Reason 5 O O
eyes. Reason 5 O O
Patients Reason 5 O O
with Reason 5 O O
COVID-19 Reason 5 O O
have Reason 5 O O
had Reason 5 O O
a Reason 5 O O
wide Reason 5 O O
range Reason 5 O O
of Reason 5 O O
symptoms Reason 5 O O
reported Reason 5 O O
- Reason 5 O O
extending Reason 5 O O
from Reason 5 O O
mild Reason 5 O O
symptoms Reason 5 O O
to Reason 5 O O
severe Reason 5 O O
illnesses, Reason 5 O O
despite Reason 5 O O
the Reason 5 O O
fact Reason 5 O O
that Reason 5 O O
the Reason 5 O O
majority Reason 5 O O
of Reason 5 O O
infected Reason 5 O O
people Reason 5 O O
are Reason 5 O O
asymptomatic Reason 5 O O
without Reason 5 O O
disease Reason 5 O O
manifestation. Reason 5 O O
Mild Reason 5 O O
to Reason 5 O O
moderate Reason 5 O O
symptoms Reason 5 O O
often Reason 5 O O
include Reason 5 O O
malaise Reason 5 O O
or Reason 5 O O
muscle Reason 5 O O
weakness, Reason 5 O O
low-grade Reason 5 O O
fever Reason 5 O O
and Reason 5 O O
sore Reason 5 O O
throat. Reason 5 O O
However, Reason 5 O O
some Reason 5 O O
patients Reason 5 O O
might Reason 5 O O
develop Reason 5 O O
life-threatening Reason 5 O O
complications Reason 5 O O
such O O O O
as O O O O
severe O O O O
lung O O O O
infection O O O O
which O O O O
can O O O O
potentially O O O O
lead O O O O
to O O O O
death. O O O O
Based O O O O
on O O O O
currently O O O O
available O O O O
information O O O O
obtained O O O O
from O O O O
clinical O O O O
studies, O O O O
the O O O O
elderly O O O O
or O O O O
patients O O O O
who O O O O
have O O O O
certain O O O O
underlying O O O O
medical O O O O
conditions, O O O O
especially O O O O
diabetes O O O O
and O O O O
cardiovascular O O O O
diseases O O O O
are O O O O
at O O O O
higher O O O O
risk O O O O
for O O O O
severe O O O O
illness O O O O
from O O O O
COVID-19. O O O O
Compared O O O O
with O O O O
the O O O O
general O O O O
population, O O O O
patients O O O O
presenting O O O O
with O O O O
these O O O O
comorbidities O O O O
appear O O O O
to O O O O
be O O O O
more O O O O
vulnerable O O O O
to O O O O
becoming O O O O
severely O O O O
ill O O O O
with O O O O
the O O O O
COVID-19. O O O O
Owing O O O O
to O O O O
the O O O O
fact O O O O
that O O O O
the O O O O
incubation O O O O
period O O O O
of O O O O
COVID-19 O O O O
(the O O O O
time O O O O
between O O O O
exposure O O O O
to O O O O
the O O O O
virus O O O O
and O O O O
symptom O O O O
onset) O O O O
is O O O O
on O O O O
average O O O O
2-14 O O O O
days, O O O O
therefore, O O O O
quarantine O O O O
should O O O O
be O O O O
strictly O O O O
in O O O O
place O O O O
for O O O O
14 O O O O
days O O O O
from O O O O
the O O O O
last O O O O
exposure O O O O
to O O O O
a O O O O
confirmed O O O O
case. O O O O
COVID-19 O O O O
Vaccines O O O O
When Reason 4 O O
different Reason 4 O O
microorganisms, Reason 4 O O
such Reason 4 O O
as Reason 4 O O
bacteria Reason 4 O O
or Reason 4 O O
viruses, Reason 4 O O
invade Reason 4 O O
the Reason 4 O O
body, Reason 4 O O
they Reason 4 O O
attack Reason 4 O O
our Reason 4 O O
immune Reason 4 O O
system. Reason 4 O O
This Reason 4 O O
invasion Reason 4 O O
eventually Reason 4 O O
becomes Reason 4 O O
an Reason 4 O O
infection. Reason 4 O O
The Reason 4 O O
immune Reason 4 O O
system Reason 4 O O
uses Reason 4 O O
several Reason 4 O O
tools Reason 4 O O
to Reason 4 O O
fight Reason 4 O O
off Reason 4 O O
infection. Reason 4 O O
Besides Reason 4 O O
red Reason 4 O O
blood Reason 4 O O
cells, Reason 4 O O
blood Reason 4 O O
also Reason 4 O O
contains Reason 4 O O
white Reason 4 O O
or Reason 4 O O
immune Reason 4 O O
cells Reason 4 O O
used Reason 4 O O
for Reason 4 O O
defense Reason 4 O O
against Reason 4 O O
infection. Reason 4 O O
These Reason 4 O O
white Reason 4 O O
cells Reason 4 O O
consist Reason 4 O O
primarily Reason 4 O O
of Reason 4 O O
macrophages, Reason 4 O O
B-lymphocytes Reason 4 O O
and Reason 4 O O
T-lymphocytes. Reason 4 O O
Macrophages Reason 4 O O
are Reason 4 O O
white Reason 4 O O
blood Reason 4 O O
cells Reason 4 O O
that Reason 4 O O
swallow Reason 4 O O
up Reason 4 O O
and Reason 4 O O
digest Reason 4 O O
these Reason 4 O O
microorganisms Reason 4 O O
as Reason 4 O O
well Reason 4 O O
as Reason 4 O O
dying Reason 4 O O
cells. Reason 4 O O
The Reason 4 O O
macrophages Reason 4 O O
leave Reason 4 O O
behind Reason 4 O O
parts Reason 4 O O
of Reason 4 O O
the Reason 4 O O
invading Reason 4 O O
germs Reason 4 O O
called Reason 4 O O
"antigens". Reason 4 O O
The Reason 4 O O
body Reason 4 O O
identifies Reason 4 O O
antigens Reason 4 O O
as Reason 4 O O
dangerous Reason 4 O O
foreign Reason 4 O O
substances Reason 4 O O
and Reason 4 O O
stimulates Reason 4 O O
antibodies, Reason 4 O O
produced Reason 4 O O
by Reason 4 O O
B-lymphocytes Reason 4 O O
to Reason 4 O O
attack Reason 4 O O
them. Reason 4 O O
T-lymphocytes, Reason 4 O O
another Reason 4 O O
type Reason 4 O O
of Reason 4 O O
defensive Reason 4 O O
white Reason 4 O O
blood Reason 4 O O
cell, Reason 4 O O
attack Reason 4 O O
cells Reason 4 O O
in Reason 4 O O
the Reason 4 O O
body Reason 4 O O
that Reason 4 O O
have Reason 4 O O
already Reason 4 O O
been Reason 4 O O
infected. Reason 4 O O
After Reason 4 O O
the Reason 4 O O
infection, Reason 4 O O
the Reason 4 O O
immune Reason 4 O O
system Reason 4 O O
remembers Reason 4 O O
what Reason 4 O O
it Reason 4 O O
learned Reason 4 O O
to O O O O
protect O O O O
the O O O O
body O O O O
against O O O O
that O O O O
disease O O O O
when O O O O
the O O O O
body O O O O
exposes O O O O
to O O O O
those O O O O
particular O O O O
germs O O O O
again. O O O O
Vaccines O O O O
help O O O O
develop O O O O
immunity O O O O
by O O O O
imitating O O O O
an O O O O
infection. O O O O
This O O O O
type O O O O
of O O O O
infection O O O O
induced O O O O
by O O O O
vaccines, O O O O
however, O O O O
almost O O O O
never O O O O
causes O O O O
illness. O O O O
In O O O O
fact, O O O O
it O O O O
activates O O O O
the O O O O
immune O O O O
system O O O O
to O O O O
produce O O O O
antibodies O O O O
and O O O O
T-lymphocytes. O O O O
Once O O O O
the O O O O
imitation O O O O
infection O O O O
induced O O O O
by O O O O
vaccines O O O O
goes O O O O
away, O O O O
the O O O O
body O O O O
is O O O O
left O O O O
with O O O O
a O O O O
supply O O O O
of O O O O
memory O O O O
T-lymphocytes, O O O O
as O O O O
well O O O O
as O O O O
B-lymphocytes O O O O
that O O O O
will O O O O
remember O O O O
how O O O O
to O O O O
fight O O O O
off O O O O
the O O O O
disease O O O O
in O O O O
the O O O O
future. O O O O
COVID-19 O O O O
vaccines O O O O
greatly O O O O
reduce O O O O
the O O O O
risk O O O O
of O O O O
SARS-CoV-2 O O O O
infection O O O O
by O O O O
working O O O O
with O O O O
the O O O O
body's O O O O
natural O O O O
defenses O O O O
to O O O O
safely O O O O
develop O O O O
immunity O O O O
to O O O O
the O O O O
disease. O O O O
However, O O O O
it O O O O
typically O O O O
takes O O O O
some O O O O
weeks O O O O
for O O O O
the O O O O
body O O O O
to O O O O
produce O O O O
immunity O O O O
against O O O O
COVID-19 O O O O
after O O O O
vaccination. O O O O
Therefore, O O O O
after O O O O
vaccination O O O O
it Reason 3 O O
is Reason 3 O O
crucial Reason 3 O O
to Reason 3 O O
follow Reason 3 O O
all Reason 3 O O
preventive Reason 3 O O
measures, Reason 3 O O
e.g. Reason 3 O O
wearing Reason 3 O O
a Reason 3 O O
mask, Reason 3 O O
frequent Reason 3 O O
hand Reason 3 O O
washing Reason 3 O O
and Reason 3 O O
keeping Reason 3 O O
social Reason 3 O O
distancing. Reason 3 O O
More Reason 3 O O
importantly, Reason 3 O O
these Reason 3 O O
vaccines Reason 3 O O
do Reason 3 O O
not Reason 3 O O
entirely Reason 3 O O
protect Reason 3 O O
everyone Reason 3 O O
from Reason 3 O O
being Reason 3 O O
infected Reason 3 O O
with Reason 3 O O
COVID-19. Reason 3 O O
In Reason 3 O O
fact, Reason 3 O O
vaccines Reason 3 O O
help Reason 3 O O
to Reason 3 O O
reduce Reason 3 O O
disease Reason 3 O O
severity Reason 3 O O
and Reason 3 O O
serious Reason 3 O O
complications Reason 3 O O
that Reason 3 O O
might Reason 3 O O
arise Reason 3 O O
if Reason 3 O O
a Reason 3 O O
person Reason 3 O O
becomes Reason 3 O O
infected. Reason 3 O O
Given Reason 3 O O
latest Reason 3 O O
information, Reason 3 O O
it Reason 3 O O
remains Reason 3 O O
unknown Reason 3 O O
how Reason 3 O O
long Reason 3 O O
the Reason 3 O O
efficacy Reason 3 O O
lasts Reason 3 O O
after Reason 3 O O
vaccination. Reason 3 O O
In Reason 3 O O
addition, Reason 3 O O
conclusive Reason 3 O O
information Reason 3 O O
is Reason 3 O O
recently Reason 3 O O
insufficient Reason 3 O O
to Reason 3 O O
determine Reason 3 O O
whether Reason 3 O O
COVID-19 Reason 3 O O
vaccines Reason 3 O O
are Reason 3 O O
efficient Reason 3 O O
in Reason 3 O O
immunocompromised Reason 3 O O
patients Reason 3 O O
or Reason 3 O O
patients Reason 3 O O
who Reason 3 O O
take Reason 3 O O
immunosuppressant Reason 3 O O
drugs. Reason 3 O O
Types Reason 3 O O
of Reason 3 O O
COVID-19 Reason 3 O O
vaccines Reason 3 O O
According Reason 3 O O
to Reason 3 O O
recent Reason 3 O O
information Reason 3 O O
provided Reason 3 O O
by Reason 3 O O
World Reason 3 O O
Health Reason 3 O O
Organization Reason 3 O O
(WHO), Reason 3 O O
vaccines Reason 3 O O
become Reason 3 O O
a Reason 3 O O
critical Reason 3 O O
new Reason 3 O O
tool Reason 3 O O
in Reason 3 O O
the Reason 3 O O
battle O O O O
against O O O O
COVID-19. O O O O
A O O O O
number O O O O
of O O O O
vaccines O O O O
with O O O O
different O O O O
manufacturers O O O O
have O O O O
been O O O O
continuously O O O O
developed O O O O
and O O O O
launched. O O O O
All O O O O
of O O O O
them O O O O
intend O O O O
to O O O O
achieve O O O O
the O O O O
same O O O O
purpose O O O O
- O O O O
immunity O O O O
to O O O O
the O O O O
virus O O O O
by O O O O
stimulating O O O O
an O O O O
immune O O O O
response O O O O
to O O O O
an O O O O
antigen O O O O
which O O O O
is O O O O
the O O O O
spike O O O O
glycoprotein O O O O
protruding O O O O
on O O O O
the O O O O
surface O O O O
of O O O O
the O O O O
virus. O O O O
The O O O O
spike O O O O
glycoprotein O O O O
plays O O O O
an O O O O
essential O O O O
role O O O O
in O O O O
virus O O O O
attachment, O O O O
fusion O O O O
and O O O O
entry O O O O
into O O O O
the O O O O
human O O O O
cell. O O O O
This O O O O
spike O O O O
glycoprotein O O O O
specifically O O O O
binds O O O O
with O O O O
host O O O O
cell O O O O
receptors O O O O
in O O O O
the O O O O
respiratory O O O O
tract O O O O
or O O O O
digestive O O O O
tract. O O O O
After O O O O
entering O O O O
the O O O O
human's O O O O
body, O O O O
viruses O O O O
start O O O O
invading O O O O
and O O O O
causing O O O O
disease O O O O
afterwards. O O O O
Recently, O O O O
there O O O O
are O O O O
four O O O O
categories O O O O
of O O O O
COVID-19 O O O O
vaccines O O O O
available. O O O O
Their O O O O
differences O O O O
lie O O O O
in O O O O
whether O O O O
they O O O O
use O O O O
a O O O O
whole O O O O
virus; O O O O
just O O O O
the O O O O
parts O O O O
of O O O O
the O O O O
germ O O O O
that O O O O
triggers O O O O
the O O O O
immune O O O O
system; O O O O
or O O O O
just O O O O
the O O O O
genetic O O O O
material O O O O
that O O O O
provides O O O O
the O O O O
instructions O O O O
for O O O O
making O O O O
specific O O O O
proteins. O O O O
Four O O O O
types O O O O
of O O O O
COVID-19 O O O O
vaccines O O O O
are O O O O
as O O O O
follows: O O O O
- O O O O
Messenger O O O O
RNA O O O O
(mRNA) O O O O
vaccine: O O O O
COVID-19 O O O O
mRNA O O O O
vaccine O O O O
gives O O O O
instructions O O O O
for O O O O
our O O O O
cells O O O O
to O O O O
make O O O O
a O O O O
harmless O O O O
piece O O O O
of O O O O
viral O O O O
spike O O O O
glycoprotein. O O O O
Once O O O O
this O O O O
genetic O O O O
material O O O O
gets O O O O
into O O O O
human O O O O
cells, O O O O
it O O O O
uses O O O O
our O O O O
cells' O O O O
protein O O O O
factories O O O O
to O O O O
produce O O O O
the O O O O
antigen O O O O
that O O O O
subsequently O O O O
triggers O O O O
an O O O O
immune O O O O
response O O O O
to O O O O
fight O O O O
against O O O O
the O O O O
disease. O O O O
- O O O O
Viral O O O O
vector O O O O
vaccine: O O O O
Viral Reason 4 O O
vector Reason 4 O O
vaccine Reason 4 O O
uses Reason 4 O O
a Reason 4 O O
modified Reason 4 O O
version Reason 4 O O
of Reason 4 O O
a Reason 4 O O
different Reason 4 O O
virus, Reason 4 O O
called Reason 4 O O
the Reason 4 O O
vector, Reason 4 O O
to Reason 4 O O
deliver Reason 4 O O
important Reason 4 O O
instructions Reason 4 O O
to Reason 4 O O
our Reason 4 O O
cells. Reason 4 O O
For Reason 4 O O
COVID-19 Reason 4 O O
viral Reason 4 O O
vector Reason 4 O O
vaccine, Reason 4 O O
the Reason 4 O O
vector Reason 4 O O
(harmless Reason 4 O O
virus) Reason 4 O O
inserted Reason 4 O O
with Reason 4 O O
genetic Reason 4 O O
material Reason 4 O O
of Reason 4 O O
SARS-CoV-2 Reason 4 O O
enters Reason 4 O O
a Reason 4 O O
cell Reason 4 O O
in Reason 4 O O
our Reason 4 O O
body Reason 4 O O
and Reason 4 O O
then Reason 4 O O
uses Reason 4 O O
the Reason 4 O O
cell's Reason 4 O O
machinery Reason 4 O O
to Reason 4 O O
produce Reason 4 O O
a Reason 4 O O
harmless Reason 4 O O
piece Reason 4 O O
of Reason 4 O O
the Reason 4 O O
virus Reason 4 O O
-a Reason 4 O O
spike Reason 4 O O
glycoprotein Reason 4 O O
that Reason 4 O O
causes Reason 4 O O
COVID-19. O O O O
Later O O O O
on, O O O O
our O O O O
immune O O O O
system O O O O
recognizes O O O O
it O O O O
as O O O O
a O O O O
foreign O O O O
substance O O O O
which O O O O
triggers O O O O
our O O O O
immune O O O O
system O O O O
to O O O O
begin O O O O
producing O O O O
antibodies O O O O
and O O O O
activating O O O O
other O O O O
immune O O O O
cells O O O O
to O O O O
fight O O O O
off O O O O
the O O O O
disease. O O O O
- O O O O
Inactivated O O O O
virus O O O O
vaccine: O O O O
Inactivated O O O O
virus O O O O
vaccine O O O O
uses O O O O
SARS-CoV-2 O O O O
viruses O O O O
whose O O O O
genetic O O O O
materials O O O O
have O O O O
been O O O O
destroyed O O O O
either O O O O
by O O O O
chemicals, O O O O
radiation O O O O
or O O O O
heat. O O O O
Thus O O O O
they O O O O
cannot O O O O
replicate, O O O O
but O O O O
can O O O O
still O O O O
trigger O O O O
an O O O O
immune O O O O
response O O O O
to O O O O
build O O O O
up O O O O
antibodies O O O O
to O O O O
fight O O O O
against O O O O
the O O O O
disease. O O O O
Protein O O O O
subunit O O O O
vaccine: O O O O
Protein O O O O
subunit O O O O
vaccine O O O O
uses O O O O
only O O O O
fragments O O O O
of O O O O
specific O O O O
protein O O O O
of O O O O
SARS-CoV-2 O O O O
virus O O O O
to O O O O
trigger O O O O
an O O O O
immune O O O O
response. O O O O
By O O O O
doing O O O O
so, O O O O
it O O O O
boosts O O O O
up O O O O
immunity O O O O
to O O O O
fight O O O O
off O O O O
COVID-19 Reason 4 O O
without Reason 4 O O
causing Reason 4 O O
any Reason 4 O O
harm Reason 4 O O
to Reason 4 O O
the Reason 4 O O
body. Reason 4 O O
Who O O O O
should O O O O
get O O O O
COVID-19 O O O O
vaccine? O O O O
Even O O O O
though O O O O
COVID-19 O O O O
vaccines O O O O
are O O O O
recommended O O O O
in O O O O
general O O O O
population, O O O O
there O O O O
seems O O O O
to O O O O
be O O O O
a O O O O
shortage O O O O
of O O O O
vaccine O O O O
supply O O O O
while O O O O
clinical O O O O
data O O O O
indicating O O O O
vaccine O O O O
safety O O O O
and O O O O
efficacy O O O O
has O O O O
been O O O O
only O O O O
derived O O O O
from O O O O
certain O O O O
groups O O O O
of O O O O
population. O O O O
In O O O O
Thailand, O O O O
therefore, O O O O
Department O O O O
of O O O O
Disease O O O O
Control O O O O
has O O O O
recommended O O O O
that O O O O
the O O O O
COVID-19 O O O O
vaccines O O O O
should O O O O
be O O O O
primarily O O O O
offered O O O O
to: O O O O
- O O O O
Health O O O O
care O O O O
personnel, O O O O
both O O O O
government O O O O
and O O O O
private O O O O
sectors O O O O
- Reason 4 O O
Patients Reason 4 O O
with Reason 4 O O
underlying Reason 4 O O
diseases, Reason 4 O O
such Reason 4 O O
as Reason 4 O O
respiratory Reason 4 O O
disease Reason 4 O O
and Reason 4 O O
cardiovascular Reason 4 O O
disease Reason 4 O O
- Reason 4 O O
People Reason 4 O O
aged Reason 4 O O
over Reason 4 O O
60 Reason 4 O O
(according Reason 4 O O
current Reason 4 O O
information Reason 4 O O
on Reason 4 O O
3 Reason 4 O O
March, Reason 4 O O
2021, Reason 4 O O
only Reason 4 O O
certain Reason 4 O O
types Reason 4 O O
of Reason 4 O O
COVID-19 Reason 4 O O
vaccines Reason 4 O O
can Reason 4 O O
be Reason 4 O O
given Reason 4 O O
to Reason 4 O O
this Reason 4 O O
group). Reason 4 O O
- Reason 4 O O
Frontline Reason 4 O O
immigration Reason 4 O O
officers Reason 4 O O
and Reason 4 O O
essential Reason 4 O O
workers, Reason 4 O O
such Reason 4 O O
as Reason 4 O O
soldiers, Reason 4 O O
policemen Reason 4 O O
and Reason 4 O O
volunteers Reason 4 O O
in Reason 4 O O
social Reason 4 O O
work. Reason 4 O O
Given O O O O
recent O O O O
information O O O O
relating O O O O
to O O O O
special O O O O
population O O O O
groups, O O O O
vaccination O O O O
in O O O O
people O O O O
aged O O O O
lower O O O O
than O O O O
18, O O O O
pregnant O O O O
or O O O O
breastfeeding O O O O
women O O O O
remains O O O O
indecisive O O O O
with O O O O
limited O O O O
clinical O O O O
studies. O O O O
The O O O O
specialist O O O O
might O O O O
consider O O O O
prescribing O O O O
COVID-19 O O O O
vaccines O O O O
if O O O O
benefits O O O O
outweigh O O O O
the O O O O
possible O O O O
risks. O O O O
COVID-19 O O O O
vaccines O O O O
in O O O O
Thailand O O O O
As O O O O
of O O O O
2 O O O O
March O O O O
2021, O O O O
COVID-19 O O O O
vaccines O O O O
available O O O O
in O O O O
Thailand O O O O
include: O O O O
- O O O O
AstraZeneca O O O O
vaccine: O O O O
AstraZeneca O O O O
vaccine O O O O
is O O O O
a O O O O
viral O O O O
vector O O O O
vaccine O O O O
that O O O O
is O O O O
proved O O O O
in O O O O
people Reason 4 O O
aged Reason 4 O O
over Reason 4 O O
18. Reason 4 O O
AstraZeneca Reason 4 O O
vaccination Reason 4 O O
course Reason 4 O O
consists Reason 4 O O
of Reason 4 O O
two Reason 4 O O
separate Reason 4 O O
doses Reason 4 O O
of Reason 4 O O
0.5 Reason 4 O O
ml Reason 4 O O
each. Reason 4 O O
The Reason 4 O O
second Reason 4 O O
dose Reason 4 O O
should Reason 4 O O
be Reason 4 O O
administered Reason 4 O O
4-12 Reason 4 O O
weeks Reason 4 O O
apart Reason 4 O O
from Reason 4 O O
the Reason 4 O O
first Reason 4 O O
dose. Reason 4 O O
It Reason 4 O O
is Reason 4 O O
for Reason 4 O O
intramuscular Reason 4 O O
(IM) Reason 4 O O
injection Reason 4 O O
only, Reason 4 O O
preferably Reason 4 O O
in Reason 4 O O
the Reason 4 O O
deltoid Reason 4 O O
muscle. Reason 4 O O
- Reason 4 O O
CoronaVac Reason 4 O O
or Reason 4 O O
SinoVac Reason 4 O O
vaccine: Reason 4 O O
CoronaVac Reason 4 O O
or Reason 4 O O
SinoVac Reason 4 O O
vaccine Reason 4 O O
is Reason 4 O O
an Reason 4 O O
inactivated Reason 4 O O
vaccine Reason 4 O O
recommended Reason 4 O O
in Reason 4 O O
people Reason 4 O O
aged Reason 4 O O
between Reason 4 O O
18-59. Reason 4 O O
Similar Reason 4 O O
to Reason 4 O O
AstraZeneca Reason 4 O O
vaccine, Reason 4 O O
Sinovac Reason 4 O O
vaccination Reason 4 O O
course Reason 4 O O
consists Reason 4 O O
of Reason 4 O O
two Reason 4 O O
separate Reason 4 O O
doses Reason 4 O O
of Reason 4 O O
0.5 Reason 4 O O
ml Reason 4 O O
each. Reason 4 O O
The Reason 4 O O
second Reason 4 O O
dose Reason 4 O O
should Reason 4 O O
be Reason 4 O O
administered Reason 4 O O
2-4 Reason 4 O O
weeks Reason 4 O O
apart Reason 4 O O
from Reason 4 O O
the Reason 4 O O
first Reason 4 O O
dose. Reason 4 O O
Route Reason 4 O O
of Reason 4 O O
administration Reason 4 O O
is Reason 4 O O
intramuscular Reason 4 O O
(IM) Reason 4 O O
injection Reason 4 O O
only, Reason 4 O O
preferably Reason 4 O O
in Reason 4 O O
the Reason 4 O O
deltoid Reason 4 O O
muscle. Reason 4 O O
For Reason 4 O O
those Reason 4 O O
who Reason 4 O O
live Reason 4 O O
in Reason 4 O O
high-risk Reason 4 O O
zones, Reason 4 O O
a Reason 4 O O
two-week Reason 4 O O
interval Reason 4 O O
is Reason 4 O O
advised Reason 4 O O
since Reason 4 O O
it Reason 4 O O
proves Reason 4 O O
the Reason 4 O O
stronger Reason 4 O O
antibody Reason 4 O O
response Reason 4 O O
in Reason 4 O O
clinical Reason 4 O O
trials Reason 4 O O
- O O O O
Johnson O O O O
and O O O O
Johnson O O O O
vaccine: O O O O
Johnson O O O O
and O O O O
Johnson O O O O
vaccine O O O O
uses O O O O
a O O O O
shell O O O O
of O O O O
a O O O O
virus O O O O
to O O O O
carry O O O O
genetic O O O O
material, O O O O
DNA O O O O
of O O O O
SARS-CoV-2 O O O O
virus O O O O
into O O O O
human O O O O
cells, O O O O
allowing O O O O
for O O O O
immunity O O O O
against O O O O
the O O O O
virus. O O O O
The O O O O
shell O O O O
has O O O O
been O O O O
modified O O O O
so O O O O
it O O O O
can O O O O
no O O O O
longer O O O O
replicate O O O O
and O O O O
cause O O O O
disease. O O O O
Unlike O O O O
AtraZenaca O O O O
and O O O O
SinoVac O O O O
vaccines, O O O O
Johnson O O O O
and O O O O
Johnson O O O O
vaccine O O O O
is O O O O
administered O O O O
as O O O O
a O O O O
single O O O O
dose O O O O
via O O O O
intramuscular O O O O
route O O O O
in O O O O
the O O O O
deltoid O O O O
muscle. O O O O
To O O O O
reach O O O O
the O O O O
maximum O O O O
efficacy O O O O
against O O O O
COVID-19, O O O O
it O O O O
is O O O O
essential O O O O
to O O O O
complete O O O O
the O O O O
course. O O O O
However, O O O O
interchangeability O O O O
of O O O O
COVID-19 O O O O
vaccine O O O O
products O O O O
(mixing O O O O
vaccines O O O O
using O O O O
different O O O O
types O O O O
and O O O O
manufacturers) O O O O
for O O O O
the O O O O
first O O O O
and O O O O
second O O O O
doses O O O O
has O O O O
not O O O O
been O O O O
yet O O O O
advised O O O O
since O O O O
no O O O O
confirmative O O O O
evidence O O O O
can O O O O
be O O O O
recently O O O O
obtained O O O O
from O O O O
clinical O O O O
trials, O O O O
although O O O O
combined O O O O
regimen O O O O
may O O O O
provide O O O O
more O O O O
protection O O O O
and O O O O
flexibility O O O O
whenever O O O O
production O O O O
of O O O O
a O O O O
vaccine O O O O
falters, O O O O
as O O O O
often O O O O
happens. O O O O
Moreover, O O O O
after O O O O
completing O O O O
a O O O O
two-dose O O O O
course O O O O
of O O O O
vaccination, O O O O
it O O O O
is O O O O
undefined O O O O
whether O O O O
an O O O O
additional O O O O
dose Reason 4 O O
is Reason 4 O O
required Reason 4 O O
with Reason 4 O O
unknown Reason 4 O O
regimen Reason 4 O O
and Reason 4 O O
interval. Reason 4 O O
Possible O O O O
side O O O O
effects O O O O
of O O O O
COVID-19 O O O O
vaccines O O O O
Undesired O O O O
reactions O O O O
caused O O O O
by O O O O
COVID-19 O O O O
vaccines O O O O
widely O O O O
vary O O O O
among O O O O
individuals. O O O O
Some O O O O
might O O O O
experience O O O O
only O O O O
mild O O O O
side O O O O
effects O O O O
or O O O O
even O O O O
none O O O O
while O O O O
some O O O O
might O O O O
develop O O O O
life-threatening O O O O
reactions. O O O O
Possible O O O O
side O O O O
effects O O O O
after O O O O
getting O O O O
COVID-19 O O O O
vaccines O O O O
include: O O O O
- O O O O
Common O O O O
side O O O O
effects:g. O O O O
pain, O O O O
redness, O O O O
itch O O O O
or O O O O
swelling O O O O
at O O O O
the O O O O
injection O O O O
site, O O O O
weakness, O O O O
fatigue O O O O
or O O O O
discomfort, O O O O
mild O O O O
headache, O O O O
low-grade O O O O
fever, O O O O
nausea O O O O
and O O O O
vomiting, O O O O
muscle O O O O
and O O O O
joint O O O O
pain. O O O O
- Reason 3 O O
Rare Reason 3 O O
or Reason 3 O O
unusual Reason 3 O O
side Reason 3 O O
effects: Reason 3 O O
high-grade Reason 3 O O
fever, Reason 3 O O
lump Reason 3 O O
or Reason 3 O O
bump Reason 3 O O
at Reason 3 O O
the Reason 3 O O
injection Reason 3 O O
site, Reason 3 O O
dizziness, Reason 3 O O
drowsiness, Reason 3 O O
palpitation, Reason 3 O O
abdominal Reason 3 O O
pain, Reason 3 O O
decreased Reason 3 O O
appetite, Reason 3 O O
excessive Reason 3 O O
sweating, Reason 3 O O
enlarged Reason 3 O O
lymph Reason 3 O O
node Reason 3 O O
and Reason 3 O O
flu-like Reason 3 O O
symptoms, Reason 3 O O
such Reason 3 O O
as Reason 3 O O
sore Reason 3 O O
throat, Reason 3 O O
runny Reason 3 O O
nose Reason 3 O O
and Reason 3 O O
cough. Reason 3 O O
Contraindications O O O O
to O O O O
COVID-19 O O O O
vaccine O O O O
- O O O O
Allergic O O O O
reaction O O O O
of O O O O
any O O O O
severity O O O O
or O O O O
known O O O O
(diagnosed) O O O O
allergy O O O O
to O O O O
a O O O O
component O O O O
of O O O O
any O O O O
vaccine. O O O O
- O O O O
Severe O O O O
allergic O O O O
reaction, O O O O
e.g. O O O O
anaphylaxis, O O O O
shortness O O O O
of O O O O
breath, O O O O
swelling O O O O
face O O O O
or O O O O
tongue O O O O
and O O O O
airway O O O O
obstruction O O O O
after O O O O
a O O O O
previous O O O O
dose O O O O
or O O O O
to O O O O
a O O O O
component O O O O
of O O O O
the O O O O
COVID-19 O O O O
vaccine. O O O O
Precautions O O O O
Important O O O O
information O O O O
that O O O O
needs O O O O
to O O O O
be O O O O
informed O O O O
physician O O O O
and O O O O
medical O O O O
personnel O O O O
prior O O O O
to O O O O
vaccination O O O O
includes: O O O O
- O O O O
Allergic O O O O
history O O O O
of O O O O
vaccines, O O O O
foods O O O O
and O O O O
other O O O O
allergens. O O O O
- O O O O
Body O O O O
temperature O O O O
greater O O O O
than O O O O
38'c O O O O
on O O O O
the O O O O
vaccination O O O O
day. O O O O
- O O O O
The Reason 3 O O
presence Reason 3 O O
of Reason 3 O O
bruise, Reason 3 O O
unusual Reason 3 O O
bleeding Reason 3 O O
or Reason 3 O O
the Reason 3 O O
use Reason 3 O O
of Reason 3 O O
anticoagulant Reason 3 O O
drug Reason 3 O O
such Reason 3 O O
as Reason 3 O O
warfarin. Reason 3 O O
- O O O O
Immune O O O O
suppression, O O O O
such O O O O
as O O O O
being O O O O
immunocompromised O O O O
host, O O O O
using O O O O
high-dose O O O O
or O O O O
long-term O O O O
corticosteroid O O O O
drugs O O O O
or O O O O
receiving O O O O
chemotherapy O O O O
or O O O O
other O O O O
immunosuppressive O O O O
agents. O O O O
- O O O O
All O O O O
side O O O O
effects O O O O
that O O O O
arose O O O O
after O O O O
the O O O O
first O O O O
dose O O O O
of O O O O
vaccination O O O O
- O O O O
Being O O O O
pregnant O O O O
or O O O O
breastfeeding O O O O
or O O O O
planning O O O O
for O O O O
pregnancy O O O O
In O O O O
case O O O O
that O O O O
mild O O O O
signs O O O O
or O O O O
symptoms O O O O
present O O O O
before O O O O
vaccination, O O O O
the O O O O
physician O O O O
might O O O O
consider O O O O
prescribing O O O O
vaccine O O O O
without O O O O
delays O O O O
if O O O O
benefits O O O O
are O O O O
distinctly O O O O
seen. O O O O
Nonetheless, O O O O
vaccination O O O O
must O O O O
be O O O O
suspended O O O O
if O O O O
severe O O O O
conditions O O O O
persist O O O O
based O O O O
primarily O O O O
upon O O O O
individual's O O O O
health O O O O
status O O O O
and O O O O
underlying O O O O
problems. O O O O
Post O O O O
vaccination O O O O
instructions O O O O
After O O O O
vaccination, O O O O
a O O O O
30-minute O O O O
observation O O O O
at O O O O
vaccination O O O O
clinic O O O O
or O O O O
hospital O O O O
is O O O O
compulsorily Reason 4 O O
required Reason 4 O O
in Reason 4 O O
order Reason 4 O O
to Reason 4 O O
monitor Reason 4 O O
possible Reason 4 O O
side Reason 4 O O
effects Reason 4 O O
caused Reason 4 O O
by Reason 4 O O
COVID-19 Reason 4 O O
vaccines. Reason 4 O O
If Reason 4 O O
any Reason 4 O O
sign Reason 4 O O
or Reason 4 O O
symptom Reason 4 O O
exhibits, Reason 4 O O
it Reason 4 O O
must Reason 4 O O
be Reason 4 O O
immediately Reason 4 O O
informed Reason 4 O O
to Reason 4 O O
physician, Reason 4 O O
pharmacist Reason 4 O O
and Reason 4 O O
nurse. Reason 4 O O
Appropriate Reason 4 O O
medical Reason 4 O O
treatment Reason 4 O O
used Reason 4 O O
to Reason 4 O O
manage Reason 4 O O
immediate Reason 4 O O
allergic Reason 4 O O
reactions Reason 4 O O
must Reason 4 O O
be Reason 4 O O
readily Reason 4 O O
available Reason 4 O O
in Reason 4 O O
the Reason 4 O O
event Reason 4 O O
an Reason 4 O O
acute Reason 4 O O
anaphylactic Reason 4 O O
reaction Reason 4 O O
occurs Reason 4 O O
following Reason 4 O O
administration Reason 4 O O
of Reason 4 O O
COVID-19 Reason 4 O O
vaccine. Reason 4 O O
Nevertheless, Reason 4 O O
some Reason 4 O O
people Reason 4 O O
might Reason 4 O O
develop Reason 4 O O
other Reason 4 O O
unwanted Reason 4 O O
reactions Reason 4 O O
which Reason 4 O O
have Reason 4 O O
not Reason 4 O O
been Reason 4 O O
reported Reason 4 O O
in Reason 4 O O
previous Reason 4 O O
clinical Reason 4 O O
trials. Reason 4 O O
In Reason 4 O O
case Reason 4 O O
that Reason 4 O O
mild Reason 4 O O
side Reason 4 O O
effects Reason 4 O O
present, Reason 4 O O
such Reason 4 O O
as Reason 4 O O
low-grade Reason 4 O O
fever Reason 4 O O
and Reason 4 O O
mild Reason 4 O O
headache, Reason 4 O O
over-the-counter Reason 4 O O
drugs, Reason 4 O O
e.g. Reason 4 O O
paracetamol Reason 4 O O
can Reason 4 O O
be Reason 4 O O
taken Reason 4 O O
to Reason 4 O O
subside Reason 4 O O
these Reason 4 O O
effects. Reason 4 O O
However, Reason 4 O O
if Reason 4 O O
serious Reason 4 O O
symptoms Reason 4 O O
manifest, Reason 4 O O
e.g. Reason 4 O O
high-grade Reason 4 O O
fever, Reason 4 O O
chills Reason 4 O O
and Reason 4 O O
severe Reason 4 O O
headache, Reason 4 O O
immediate Reason 4 O O
medical Reason 4 O O
attention Reason 4 O O
must Reason 4 O O
be Reason 4 O O
sought. Reason 4 O O
For Reason 4 O O
safety Reason 4 O O
purpose, Reason 4 O O
it Reason 4 O O
is Reason 4 O O
important Reason 4 O O
to Reason 4 O O
keep Reason 4 O O
vaccination Reason 4 O O
booklet Reason 4 O O
or Reason 4 O O
record Reason 4 O O
for Reason 4 O O
vaccine O O O O
tracking. O O O O
Besides O O O O
healthcare O O O O
crisis O O O O
induced O O O O
by O O O O
COVID-19 O O O O
pandemic O O O O
started O O O O
in O O O O
the O O O O
end O O O O
of O O O O
2019, O O O O
the O O O O
economic O O O O
and O O O O
social O O O O
disruption O O O O
caused O O O O
by O O O O
this O O O O
pandemic O O O O
is O O O O
enormously O O O O
devastating. O O O O
COVID-19 O O O O
vaccines O O O O
as O O O O
a O O O O
novel O O O O
weapon O O O O
to O O O O
battle O O O O
against O O O O
COVID-19 O O O O
are O O O O
considered O O O O
"a O O O O
game O O O O
changer" O O O O
for O O O O
preventing O O O O
people O O O O
across O O O O
the O O O O
world O O O O
from O O O O
the O O O O
disease O O O O
while O O O O
reducing O O O O
disease O O O O
severity O O O O
and O O O O
confining O O O O
virus O O O O
spreading. O O O O
The O O O O
COVID-19 O O O O
pandemic O O O O
has O O O O
urgently O O O O
prompted O O O O
scientists O O O O
from O O O O
around O O O O
the O O O O
world O O O O
to O O O O
design O O O O
anti-SARS-CoV-2 O O O O
vaccines. O O O O
The O O O O
availability O O O O
of O O O O
advanced O O O O
science O O O O
data O O O O
has O O O O
allowed O O O O
creating O O O O
different O O O O
types O O O O
of O O O O
vaccine O O O O
based O O O O
on O O O O
innovative O O O O
platforms O O O O
and O O O O
directed O O O O
towards O O O O
well O O O O
defined O O O O
sensible O O O O
targets. O O O O
Nonetheless, Reason 3 O O
the Reason 3 O O
development Reason 3 O O
of Reason 3 O O
these Reason 3 O O
vaccines Reason 3 O O
in Reason 3 O O
a Reason 3 O O
very Reason 3 O O
short Reason 3 O O
time Reason 3 O O
necessarily Reason 3 O O
implies Reason 3 O O
that Reason 3 O O
is Reason 3 O O
not Reason 3 O O
yet Reason 3 O O
possible Reason 3 O O
to Reason 3 O O
anticipate Reason 3 O O
their Reason 3 O O
long-term Reason 3 O O
efficacy Reason 3 O O
and Reason 3 O O
possible O O O O
side O O O O
effects O O O O
as O O O O
well O O O O
as O O O O
the O O O O
use O O O O
in O O O O
special O O O O
population. O O O O
Therefore, O O O O
the O O O O
future O O O O
trend O O O O
of O O O O
clinical O O O O
studies O O O O
should O O O O
involve O O O O
medicines O O O O
used O O O O
to O O O O
treat O O O O
COVID-19 O O O O
and O O O O
vaccines O O O O
that O O O O
can O O O O
fully O O O O
protect O O O O
all O O O O
variants O O O O
of O O O O
SARS-CoV-2 O O O O
virus. O O O O
References: O O O O
- O O O O
World O O O O
Health O O O O
Organization O O O O
(WHO) O O O O
[Internet] O O O O
[Cited O O O O
2021 O O O O
February O O O O
28] O O O O
Status O O O O
of O O O O
COVID-19 O O O O
Vaccines O O O O
within O O O O
WHO O O O O
EUL/PQ O O O O
evaluation O O O O
process. O O O O
Available O O O O
from: O O O O
[https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_01March2021.pdf](https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_01March2021.pdf) O O O O
- O O O O
World O O O O
Health O O O O
Organization O O O O
(WHO) O O O O
[Internet] O O O O
[Cited O O O O
2021 O O O O
March O O O O
3] O O O O
COVID-19 O O O O
- O O O O
Landscape O O O O
of O O O O
novel O O O O
coronavirus O O O O
candidate O O O O
vaccine O O O O
development O O O O
worldwide. O O O O
Available O O O O
from O O O O
: O O O O
[https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines](https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines) O O O O
- O O O O
World O O O O
Health O O O O
Organization O O O O
(WHO) O O O O
[Internet] O O O O
[Cited O O O O
2021 O O O O
March O O O O
3] O O O O
ROADMAP O O O O
FOR O O O O
PRIORITIZING O O O O
POPULATION O O O O
GROUPS O O O O
FOR O O O O
VACCINES O O O O
AGAINST O O O O
COVID-19. O O O O
Update O O O O
27 O O O O
September O O O O
2020. O O O O
Available O O O O
from O O O O
https://www.who.int/immunization/sage/meetings/2020/october/Session03_Roadmap_Prioritization_Covid-19_vaccine.pdf O O O O
- O O O O
Package O O O O
leaflet. O O O O
Information O O O O
for O O O O
the O O O O
recipient O O O O
COVID-19 O O O O
Vaccine O O O O
AstaZeneca O O O O
solution O O O O
for O O O O
injection. O O O O
Update O O O O
December O O O O
2020 O O O O
- O O O O
Centers O O O O
for O O O O
Disease O O O O
Control O O O O
and O O O O
Prevention O O O O
(CDC) O O O O
[Internet] O O O O
[Cited O O O O
2021 O O O O
March O O O O
1] O O O O
COVID-19 O O O O
Vaccine: O O O O
Helps O O O O
protect O O O O
you O O O O
from O O O O
getting O O O O
COVID-19. O O O O
Available O O O O
from: O O O O
[https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html](https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html) O O O O
- O O O O
Centers O O O O
for Reason 3 O O
Disease Reason 3 O O
Control Reason 3 O O
and Reason 3 O O
Prevention Reason 3 O O
(CDC) Reason 3 O O
[Internet] Reason 3 O O
[Cited Reason 3 O O
2021 Reason 3 O O
March Reason 3 O O
1] Reason 3 O O
Understanding Reason 3 O O
How Reason 3 O O
COVID-19 Reason 3 O O
Vaccines Reason 3 O O
Work Reason 3 O O
Updated Reason 3 O O
Jan. Reason 3 O O
13, Reason 3 O O
202. Reason 3 O O
Available Reason 3 O O
from Reason 3 O O
: Reason 3 O O
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html Reason 3 O O
- Reason 3 O O
[ Reason 3 O O
internet] Reason 3 O O
[Cited Reason 3 O O
2021 Reason 3 O O
February Reason 3 O O
20] Reason 3 O O
. Reason 3 O O
19 Reason 3 O O
64 Reason 3 O O
. Reason 3 O O
2564 Reason 3 O O
For Reason 3 O O
more Reason 3 O O
information, Reason 3 O O
please Reason 3 O O
contact Reason 3 O O
Internal Reason 3 O O
Medicine Reason 3 O O
Clinic Reason 3 O O
Share Reason 3 O O
